Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-055200

Director sold 55,364 shares at an average $29.20 ($1,616,749)

From the SEC's structured data for this filing

Trades in this filing

GADICKE ANSBERT · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-03 Sale : show line 1 in the form −1,760 $29.60 $52,096 255,032 D
2021-09-03 Sale : show line 2 in the form −12,731 $29.60 $376,838 7,724,085 I
2021-09-07 Sale : show line 3 in the form −3,465 $29.04 $100,624 251,567 D
2021-09-07 Sale : show line 4 in the form −25,067 $29.04 $727,946 7,699,018 I
2021-09-08 Sale : show line 5 in the form −1,499 $29.11 $43,636 250,068 D
2021-09-08 Sale : show line 6 in the form −10,842 $29.11 $315,611 7,688,176 I
Open-market sales · 55,364 sh · avg $29.20 · $1,616,749
Loading xslF345X03/doc4.xml…